Overview
Announcements

Ordinary Reweighting | Several Solactive Indices | Effective Date 2nd October 2023

RBC Biotech Opportunities GTR Index:

In the ordinary reweighting, the following composition will be implemented effective open 02.10.2023:

ABBVIE INC
ALNYLAM PHARMACEUTICALS INC
BIOGEN INC
BIOMARIN PHARMACEUTICAL INC
ELI LILLY & CO
GILEAD SCIENCES INC
INCYTE CORP
INTRA-CELLULAR THERAPIES INC
KARUNA THERAPEUTICS INC
SAREPTA THERAPEUTICS INC
SEAGEN INC

RBC Biotech Opportunities GTR Index Series 2:

In the ordinary weighting, the following composition will be implemented effective open 02.10.2023:

ABBVIE INC
AGIOS PHARMACEUTICALS INC
ALNYLAM PHARMACEUTICALS INC
AMGEN INC
BIOGEN INC
ELI LILLY & CO
GILEAD SCIENCES INC
INCYTE CORP
INTRA-CELLULAR THERAPIES INC
KARUNA THERAPEUTICS INC
PACIRA BIOSCIENCES INC
SAREPTA THERAPEUTICS INC
SEAGEN INC
XENON PHARMACEUTICALS INC

RBC Global Low Carbon Transition GTR Index:

In the ordinary weighting, the following composition will be implemented effective open 02.10.2023:

AIR LIQUIDE SA
ANALOG DEVICES INC
ANGLO AMERICAN PLC
APTIV PLC
ASML HOLDING NV
ASSA ABLOY AB CLASS B
DEERE & CO
ENEL SPA
IBERDROLA SA
NATIONAL GRID PLC
NIDEC CORP ORD
ORSTED A/S
RWE AG
SCHNEIDER ELECTRIC SE
SIEMENS AG
SMURFIT KAPPA GROUP PLC
UNION PACIFIC CORP
XYLEM INC